Articles tagged with Bacterial Pathogens
Scientists at Ohio State University have created a treatment for late-stage sepsis using nanotechnology to transform donated immune cells into a powerful antibacterial drug. The therapy demonstrated significant improvements in survival rates and bacteria clearance in mouse models of sepsis.
Certain bacteria, such as Shigella, use lipopolysaccharides to block caspases and prevent apoptosis, allowing them to multiply intracellularly. This strategy is essential for their survival and spread within the human body.
Researchers discovered that the human body uses a receptor to detect bacterial quorum sensing molecules, enabling it to react to differing stages of an infection. This allows the body to save energy by not reacting prematurely and prevents collateral damage caused by the immune system's response.
A host sensor called AhR helps the immune system respond to bacterial infections by detecting and adapting to quorum sensing signals. This allows for tailored defense mechanisms against highly resistant pathogens like Pseudomonas aeruginosa.
Researchers found that humidity and aspect of the tick's environment impact the types of bacteria carried by ticks. Borrelia afzelii is more common in humid slopes facing north, while Rickettsia species are prevalent on drier, steeper slopes.
Researchers developed a new ELISpot blood test to diagnose bacterial infections, including Mycoplasma pneumoniae, which can trigger skin and mucous membrane lesions in children. The test detects specific immune cells targeted against M. pneumoniae, allowing for more specific treatment and prognosis.
A highly contagious intestinal bacteria, Shigellosis can cause 190 million cases of diarrhoea globally each year. In Victoria, a drug-resistant Shigella strain has emerged, making treatment with oral antibiotics impossible, requiring hospitalization and intravenous antibiotics instead.
A research team has identified essential proteins for archaeal motility and its structure, revealing a complex protein complex that enables archaella to swim. The discovery provides insights into the unique mechanism of archaeal movement, distinct from bacterial flagellum-based locomotion.
A recent study published in Respiratory Research found that vaping may have similar effects on harmful lung bacteria as smoking. Researchers compared the effects of cigarette smoke and e-cigarette vapor on four types of bacteria associated with smoking-related illnesses, including chronic obstructive pulmonary disease (COPD) and asthma.
Macrophages change their metabolism drastically after coming into contact with bacteria, triggering an inflammatory response. This process involves the activation of Toll-like receptors, which leads to histone acetylation and changes in gene expression.
Researchers have successfully replaced bacterial toxins with proteins in nano-syringes, enabling targeted delivery of drugs to specific body cells. The innovation aims to introduce drugs into cancer cells with minimal side effects.
Researchers at Rice University and Texas A&M University developed molecular drills that target and kill antibiotic-resistant bacteria. The drills, which can be activated with light, increase the effectiveness of existing antibiotics, offering a potential solution to superbug infections.
Researchers at Princeton University have developed new computational and experimental tools to identify microbial small molecules encoded in clinical samples. This allows scientists to explore microbial-host interactions and mine the human microbiome for drug discovery, revealing potential antibiotics and insights into human-microbe in...
Researchers have found a way to stimulate skin cells to secrete naturally occurring antibiotics called Antimicrobial Peptides, which target and kill bacteria. By modulating caspase-8 levels in the skin, AMP release can be controlled to prevent infections in diabetics and patients with weakened immune systems.
Researchers at UMSOM are testing a combined Shigella-ETEC vaccine to offer protection against diarrheal diseases, which cause millions of deaths worldwide. The vaccine has been developed with $4.5 million funding from Emergent BioSolutions.
Researchers discovered that Stenotrophomonas maltophilia uses a secretion system to inject toxins into competing bacteria, eliminating them. The study also identified a key toxin molecule that can reduce bacterial replication rates.
The discovery of LiaX, a secret protein that alerts bacteria to antibiotic and immune system attacks, opens doors for future treatment options against antibiotic-resistant superbugs. The protein's activation causes restructuring of the bacterial cell, preventing antibiotics from destroying it.
Researchers have developed a genetic typing method for Pseudomonas putida, which enables the detection of its virulent strains. The study's findings highlight the bacterium's biotechnological value and its importance in understanding disease-causing pathogens.
A new online tool called Uniqprimer has been developed to detect blackleg disease in potatoes with high accuracy and ease of use. It quickly designs species-specific DNA tags for detecting pathogens using DNA testing, allowing for accurate pathogen detection and informing farmers' on-farm decision making.
A recent study at Massachusetts General Hospital has uncovered evidence of fimbriae that aid adherence to epithelial cells, an important step in the start of a shigellosis infection. The research team used in vivo-like culture methods and human intestinal organoids to confirm their findings.
A study on olive baboons found that females avoid mating if either the male or female shows visible signs of infection, while males do not change their behavior. The researchers aim to understand how sexually transmitted diseases impact non-human primate populations.
Researchers analyzed bushmeat samples from Tanzania's Serengeti National Park and found 27 different groups of bacteria, including those causing anthrax, brucellosis, and Q fever. The team identified a high prevalence of Clostridial species, which cause diseases like botulism and tetanus.
Researchers describe how ancestral origins impact the likelihood of developing immune-related diseases, including Crohn's disease and cardiovascular diseases. The human immune system is evolving depending on a person's location or lifestyle, leading to new diseases emerging as our lifespans increase.
Researchers found that a specific toxin in Staphylococcus aureus prevents tolerance and maintains the immune system's vigilance. Early-life exposure to commensal bacteria like S. epidermidis leads to immune tolerance, while later exposure to pathogenic S. aureus results in a vigorous immune response.
Researchers discovered a fear-greed tradeoff in bacteria that use ancient respiratory quinones for aerobic respiration, leading to oxidative stress and growth limitations. The study provides fundamental insights into microbial bioenergetics evolution and potential strategies for modulating bacterial growth and survival.
Researchers at University of Jyväskylä found that bacteria-infecting viruses preferentially bind to mucosal surfaces, providing extra immunity against bacterial infections. This symbiotic model shows phages enriched in mucus, where encounters with host bacteria are more probable.
A study by University of Basel researchers found that a cellular pump restricts bacterial growth in host cells by causing magnesium shortage. This discovery provides new insights into the role of NRAMP1 transporter in combating intracellular pathogens.
Researchers have discovered a novel peptide, Darobactin, effective against antibiotic-resistant gram-negative bacteria. The substance binds to the BamA protein, disrupting the bacterial external membrane and leading to its death. This finding presents a promising lead for developing a new antibiotic.
The BacFITBase database identifies key genes for host cell invasion and infection, aiding in the development of new antibiotics. The database contains over 90,000 entries with information on specific pathogenic bacterial genes and their contribution to infectious conditions in five different host species.
A team of scientists has discovered 79 new types of bacteria with potential to produce unique antibiotics. The researchers, led by Christian Jogler, found that these Planctomycetes have complex lifestyles and the ability to produce small molecules like antibiotics.
Researchers at Cornell University have discovered a unique bacterial regulatory mechanism called T-boxes, which facilitate basic functioning in bacteria. Understanding the structure of these elements could lead to designing targeted antibiotics, offering hope against antibiotic-resistant pathogens.
A new function of Pseudomonas aeruginosa lectin LecB has been discovered: it blocks the cell cycle in host cells, leading to slowed or halted wound healing. This impairment occurs through the silent internalization of growth factor receptors, triggering intense vacuolization and cell death.
Researchers discovered that Crohn's disease-associated bacteria can switch between replicating and non-growing states within macrophages to tolerate antibiotics. This stress response allows a reservoir of antibiotic-tolerant bacteria to survive in the host and cause long-term inflammation and irritation.
The study reveals that bacteria have multiple oxidases, with cytochrome bd oxidase playing a crucial role in energy production and stress protection. The novel findings provide insights into the development of new antimicrobials targeting pathogens.
A study in eLife reveals how respiratory bugs in cystic fibrosis patients interact, influencing disease progression and survival. The research found that one bacterium enhances the movement of another, while others significantly increase its mobility.
Researchers have published protocols for culturing Liberibacter crescens, a genetically similar bacterium, to study citrus greening. This advance enables the scientific community to use L. crescens as a realistic surrogate host for Ca. L. asiaticus.
Researchers at Martin-Luther-Universität Halle-Wittenberg have developed new active ingredients that target the pyruvate kinase enzyme in pathogenic bacteria. These substances were shown to be effective against staphylococcus and MRSA, potentially offering a solution to the growing problem of antibiotic resistance.
Scientists adapted a genetic tool to modify virulence factors in zoonotic Chlamydia, revealing distinct sets of factors determine host infection and disease. The study sheds light on the molecular mode of action of SinC and IncA, opening new avenues for investigating these pathogens.
Research reveals that E. coli bacteria gain a competitive advantage over beneficial microbes in inflammatory bowel disease (IBD) by adapting their dietary preferences to amino acids, particularly serine. This finding suggests that a low-serine diet may help control the overgrowth of pathogenic E. coli.
Researchers at the University of Sheffield have discovered that a bacterial toxin, lysostaphin, targets and breaks down MRSA cell walls, making it effective against antibiotic-resistant superbugs. This finding could lead to the development of new treatments targeting the same mechanism.
The UMass Amherst researchers have developed a portable sensing device capable of detecting and subtyping foodborne pathogens, including bacteria and viruses. This technology has the potential to quickly identify outbreaks and pinpoint the responsible food or ingredient.
Researchers have discovered a mechanism behind bacterial evolution of drug resistance, exploiting collateral sensitivity for novel and sustainable treatments. The study found that certain drugs can be used in combination to eliminate bacterial populations or prevent the emergence of multidrug resistance.
Researchers developed a novel genomic analysis method for classifying Yersinia strains, revealing unexpected biodiversity and new species. The tool enables accurate identification of pathogenicity, guiding patient monitoring and public health initiatives.
A HHU-led research consortium aims to eliminate the deadly disease bacterial blight in rice, a staple crop for over half of the world's population. The team has developed resistant rice varieties and a diagnostic kit to combat the disease, which can devastate smallholder farmers' crops.
Researchers identified specialized 'adventurer' cells in Vibrio parahaemolyticus that facilitate its dissemination and prevalence. These cells enable the bacterium to colonize new habitats and spread disease globally.
Scientists discovered that bacterial cell division requires both mechanical and biological processes. The study found that a build-up of mechanical stress in the cell wall is necessary before division occurs, and can even be triggered by physical pressure.
Researchers discovered a single nucleotide mutation in P. aeruginosa that caused rapid resistance to ceftolozane-tazobactam and partial resensitization to carbapenems and piperacilline-tazobactam. This finding may enable the use of these antibiotics in treating extremely drug-resistant P. aeruginosa cases.
A study on Ötzi's DNA found a decrease in Prevotella copri, a common human gut microbe, in Westernized populations. The discovery suggests that Westernization may have contributed to the loss of beneficial bacteria, with significant implications for public health.
A novel approach to tackle superbugs has been discovered using nanocapsules made of natural ingredients, which can prevent bacteria from attaching to stomach cells. The research aims to reduce antibiotic-resistant strains and is a potential preventative measure.
A new study from MIT reveals that glycans in mucus can disarm opportunistic pathogens and prevent infections. The researchers found that these sugar molecules can regulate the behavior of microbes, preventing them from communicating with each other and forming infectious biofilms.
Researchers develop technique to trick bacteria into revealing hundreds of holes in their cell walls, making them vulnerable to drugs. This could lead to more effective or antibiotic-free treatments that target these pores.
Researchers found that nanostructured surfaces reduce bacterial adhesion, making it harder for Staphylococcus aureus bacteria to form biofilms and resist antibiotics. The study suggests optimizing surface topography can minimize bacterial attachment and prevent biofilm formation.
Researchers identified glycerol monolaurate in human breast milk as a compound fighting pathogenic bacteria while allowing beneficial bacteria to thrive. Human breast milk has more than 200 times the amount of GML found in cows' milk and infant formula.
Researchers have developed engineered viruses to target specific strains of bacteria, reducing the risk of antibiotic resistance. The new approach could provide a targeted alternative to traditional antibiotics.
Vibrio cholerae uses its type VI secretion system (T6SS) to compete with other bacteria and acquire new genetic material, leading to rapid evolution and pathogen emergence. The bacterium can steal up to 150,000 nucleic acid base pairs, or roughly 150 genes, in a single attack.
A graphene filter developed by Rice University scientists can capture and sanitize airborne pathogens, including bacteria, fungi, and viruses. The filter uses Joule heating to kill trapped microbes and their toxic byproducts, potentially reducing hospital infections.
A new analysis found that the current annual US sales of new antibiotics to treat carbapenem-resistant Enterobacteriaceae (CRE) is $101 million, significantly short of the needed $1 billion. This shortfall threatens the financial viability of new antibiotic development and may lead to reduced treatment options for patients. Researchers...
A team of researchers from Charité - Universitätsmedizin Berlin has identified a new endogenous mechanism that enables the skin to actively kill bacteria. The discovery involves mast cells and interleukin 6, which stimulate the release of antimicrobial peptides that target bacteria.
Scientists have elucidated the structure of the ClpX-ClpP proteolytic complex, a key to developing innovative antibiotics that target bacterial degradation processes. The complex's unique mechanism of action has considerable innovation potential in the fight against pathogenic bacteria.
The Bacterial and Viral Bioinformatics Resource Center combines two independent resources to support richer scientific data and more powerful analytic tools. The hub will provide rapid access to genomic datasets, computational tools, and artificial intelligence techniques to analyze data and make predictions.